A consumer reported on behalf of a patient with an implantable neurostimulator indicated for gastrointestinal/pelvic floor.They stated that there was a revision on (b)(6) 2017.In (b)(6) 2017, it was found that the leads were "misfiring" and it was "firing way higher than it should have been".At that time, they stopped using the affected lead and changed to use the other lead.The patient then had a return of symptoms in (b)(6) 2017.They began throwing up and they were in pain.At the beginning of (b)(6) 2017, they went to see their healthcare provider (hcp) again and they speculated that time that the lead had either become disconnected or head eroded through the stomach wall.The hcp then turned off the device and scheduled a replacement surgery.During the surgery, it was found that there were no issues with the leads, so only the ins was replaced.When the two old leads were connected to the new ins, the system was functioning fine.The hcp told the patient and the consumer that the ins was "fried" and asked them if the patient had been around any significant sources of emi.The consumer stated that the patient had been around a state of the art electric wheelchair with a "nf22" battery and wondered if that could affect the device.It was reviewed that it would be unexpected.The patient had been around the wheelchair since 2016 and they were unsure if it was a significant emi source.No further complications were reported/anticipated.
|